Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

Share Price is delayed by 15 minutes
Get Live Data
2.625    -0.05 (-1.85%)
Bid:
2.60
Ask:
2.65
Spread: 0.05 (1.923%)
Market Cap: £118.59m
AEX Live PriceLast checked at - London Stock Exchange

Intraday Aminex Share Chart

Placing and Open Offer

30 Jun 2009 07:00

RNS Number : 7342U
Aminex PLC
30 June 2009
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE IN OR INTO THE UNITEDΒ STATES,Β AUSTRALIA,Β CANADA,Β JAPANΒ ORΒ SOUTH AFRICAΒ OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

This announcement is an advertisement and not a prospectus and investors should not subscribe for or purchase any shares referred to in this announcement except on the basis of information inΒ theΒ ProspectusΒ inΒ connection with theΒ Placing andΒ Open OfferΒ to be published in due course (the "Prospectus").Β Β Copies of the Prospectus will, following publication, be available,Β inter alia,Β at www.aminex-plc.com.

30Β JuneΒ 2009

Aminex PLC ("Aminex" or the "Company")

PlacingΒ to raise US$11.45Β millionΒ andΒ proposedΒ Open OfferΒ toΒ raise up to US$3Β millionΒ 

Highlights

Intention to placeΒ 116,330,998Β newΒ Ordinary Shares at Stg6p per share to raise StgΒ£6.98Β million (approximatelyΒ US$11.45Β million) before expenses (the "Placing");

Intention to conduct a non-underwritten Open Offer to qualifying shareholders of up to 30,266,841 Ordinary Shares on the basis of 1 new Ordinary Share for every 8 existing Ordinary Shares held on a record date (to be determined) at Stg6p per share to raise up to StgΒ£1.82 million (approximately US$3 million) before expenses (the "Open Offer");

Proceeds of the intended Placing and Open Offer to fund Aminex's exploration and development programme;

The Placing and theΒ Open OfferΒ are conditional,Β inter alia, upon shareholder approval to be sought at an extraordinary general meeting of the Company;

2007 warrants to be extended for 12 months to August 2010;Β and

Appointment of Astaire SecuritiesΒ as the Company'sΒ LondonΒ broker.

Proposed Placing andΒ OPEN OFFER

The Board of Aminex is pleased to announce that Astaire Securities (as bookrunner) and Davy are arranging a Placing to raise gross proceeds of approximately StgΒ£6.98 million (approximately US$1.45 million) by way of a placing of 116,330,998 new Ordinary Shares of nominal value €0.06 each at a price of Stg6p each ("Placing Shares") with new and existing institutional investors. The Placing will represent approximately 47% of the existing issued share capital.

The Board also announces its intention to give Aminex shareholders an opportunity to participate in the fundraising by way of a 1 forΒ 8Β Open OfferΒ of up toΒ 30,266,841Β new Ordinary Shares of nominal value €0.06 each at a price of Stg6p each ("Open OfferΒ Shares") to raise up to an additionalΒ StgΒ£1.82m (approximatelyΒ US$3million). Participants in the Placing will not have an entitlement to participate in theΒ Open OfferΒ in respect of their Placing Shares. Shareholders will be able to apply under the Open Offer for shares in excess of their entitlements. To the extent that excess applications are received, such applications will be scaled backΒ pro rataΒ such that funds raised from the Open Offer will not exceedΒ StgΒ£1.82Β million.Β Β Astaire Securities and Davy have reserved the right to place any unsubscribed Open Offer Shares for the benefit of the Company at the Placing Price of Stg6p, for a period of up toΒ 7Β days following the closing date of the Open Offer.

Relative to the closing market price per Ordinary Share on the London Stock Exchange on 29 June 2009 (the last business date prior to this announcement) of Stg8p, the issue price under the Placing and the Open Offer represents a discount of approximately 25%.

The net proceeds of the Placing of approximately StgΒ£6.2Β million (after estimated expenses) are intended to be used,Β in conjunction with the Company's existing cash resources, toΒ facilitateΒ Aminex'sΒ exploration andΒ developmentΒ programmeΒ and to supplement working capital.Β Β The proceeds will primarily be used for exploration and appraisal activity in East Africa and in particular to finance the Company's share of theΒ Mikindani-1 wellΒ which is scheduled to be drilled on the Company'sΒ RuvumaΒ licence in the third quarter of 2009Β in partnership with Tullow Oil plc. The ultimate cost of this wellΒ to AminexΒ may be less than budgeted as theΒ Company is in the process of seeking farm-in partners.Β Β Net proceeds of the Open Offer are intended to be used to advance the Company'sΒ exploration andΒ developmentΒ programmeΒ in theΒ USAΒ andΒ East Africa.

The implementation of the Placing, which is not underwritten, is conditional,Β inter alia,Β onΒ shareholder approval and on admissionΒ of the Placing Shares.Β TheΒ Open Offer, which is not underwritten,Β will beΒ conditional,Β inter alia,Β on shareholder approval andΒ upon the Placing having become unconditional in all respects.

PROSPECTUS, CIRCULAR AND GENERAL MEETING

An extraordinary general meeting will be held onΒ 12Β noonΒ on 23 July 2009Β atΒ The Charlotte Street Hotel,Β Charlotte Street,Β LondonΒ W1T 1RJ,Β United KingdomΒ (the "EGM"). The purpose of the EGM is to consider and, if thought fit, to passΒ theΒ resolution necessary to authorise and carry out the Placing and Open Offer.

A circular containing a notice of extraordinary general meeting will be sent to Shareholders in due course. Shareholders should read the full text of theΒ resolution contained in the Notice of General Meeting in the Circular.Β 

In connection with the Placing and Open Offer, the CompanyΒ will publish a Prospectus containingΒ full details, including the terms and conditions, of the Placing and Open Offer whichΒ will beΒ available toΒ Shareholders on the Company's websiteΒ (www.aminex-plc.com)Β and at its registered office. It is anticipated that the Prospectus, subject to the approval of the Financial Regulator,Β will be published on or aboutΒ 17Β JulyΒ 2009.

Proposed extension of the 2007 Warrants exercise period

In conjunction with an equity placingΒ and rights issueΒ undertaken in May 2007, the Company granted warrants to investors on the basis of 1 warrant for every 2 Ordinary Shares subscribed for under theΒ funding. Each warrant entitles the holder to subscribe for 1 Ordinary Share at a price ofΒ StgΒ 22p each. The warrants are exercisable at anytime up to 31 August 2009.

As of the date of thisΒ announcement, there were approximatelyΒ 36Β .4 millionΒ warrants in issue and in the event that all such warrants were exercised, approximately StgΒ£8Β million would be paid to the Company which couldΒ beΒ used to advance the Company's exploration andΒ developmentΒ programme. Taking into consideration the current market price of theΒ Company's ordinaryΒ shares, the Directors believe that it is unlikely that these warrants will be exercised prior to theirΒ expiryΒ on 31 August 2009Β and the potential proceeds will be forgone. Consequently the Directors intend to extend the exercise period of the warrants by an additionalΒ 12Β months. The DirectorsΒ believe thatΒ this would beΒ in theΒ bestΒ interest of the Company and theΒ shareholders as a whole.Β The extension of the exercise period requires the approval of a special resolution of theΒ warrant holders which will be proposed in due course.

Brian Hall,Β ChairmanΒ commented:

"TheΒ oversubscribed placing being arranged by Astaire Securities and Davy will enable Aminex to move forward with itsΒ explorationΒ and developmentΒ programmes, commencing with the drilling of the first wellΒ in the RuvumaΒ Basin ofΒ TanzaniaΒ where a firstΒ well is scheduledΒ to beΒ spuddedΒ in theΒ next three months.Β We are pleased to welcome Astaire Securities as ourΒ LondonΒ broker whichΒ will be working alongsideΒ Davy,Β our existing Irish broker."

Further Information

The Placing, which is not underwritten, is being arranged byΒ Astaire Securities and Davy. The Placing is conditional, inter alia,Β onΒ (i)Β shareholder approval; (ii)Β the PlacingΒ Agreement becoming unconditional in all respects as regards the Placing;Β andΒ (iii)Β admission of the Placing Shares to theΒ OfficialΒ Lists of the Irish Stock Exchange and the UK Listing Authority and to trading on the main markets for listed securities of the Irish Stock Exchange and the London Stock Exchange.Β The Placing is not conditional upon theΒ Open Offer.Β Β TheΒ Open Offer, which is not underwritten, is conditional,Β inter alia, uponΒ shareholder approval andΒ the Placing having become unconditional in all respects.Β Β Further announcements will be made by Aminex, including an announcement detailing the expected timetable in connection with the Open Offer, in due course.

For further information:

Aminex

Brian Hall, Chairman

Tel: +44 (0) 20 72913100

Davy

Β 

EugenΓ©e Mulhern / Brian Garrahy

Tel: +353 (0) 1 6796363Β 

Astaire Securities

Jerry Keen / Shane GallweyΒ 

Tel: + 44 (0)Β 20 7448 4492

Pelham Public Relations

Archie Berens

Tel: +44 (0) 20 7337 1509

J&E Davy (collectively ''Davy'') (each of which is regulated in Ireland by the Irish Financial Services Regulatory Authority) andΒ Astaire SecuritiesΒ plcΒ (''Astaire Securities") (which is regulated in the UK by the Financial Services Authority) are acting exclusively for Aminex in connection with the requirements of the Irish Stock Exchange and the UK Listing Authority and for no one else and will not be responsible to any other person for providing the protection afforded to customers ofΒ Astaire Securities orΒ DavyΒ respectivelyΒ nor for providing advice in connection with this announcement.

Participation in the proposedΒ Open OfferΒ will not be available to shareholders resident in theΒ United States,Β Australia,Β Canada,Β South AfricaΒ orΒ JapanΒ or any other jurisdiction where it would be unlawful to offer participation.

This announcement does not constitute, or form part of, an offer of, or the solicitation of any offer to subscribe for or buy, any of the Ordinary Shares to be issued or sold in connection with the Placing and/orΒ Open Offer.Β Investors should not subscribe for or purchase any securities referred to in this announcementΒ except on the basis of information in the Prospectus to be published by the Company in due course in connection with the Placing andΒ Open Offer.

The offer of the Ordinary Shares in certain jurisdictions may be restricted by law and therefore potential investors should inform themselves about and observe any such restrictions. This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in which such publication or distribution would be a violation of the relevant laws of such jurisdiction. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of Ordinary Shares in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in which such offer or invitation would be a violation of the relevant laws of such jurisdiction. In particular, the Placing and Open Offer will not be an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offering of Ordinary Shares in Aminex in the United States. The Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended ('the Securities Act'), or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered or sold in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.Β 

Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser.

The distribution of this announcement may be restricted by law. No action has been taken that would permit the possession or distribution of this announcement in any jurisdiction where action for that purpose is required.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOECKCKQCBKDCAB
Date   Source Headline
29th May 20144:25 pmRNSIssue of Equity
22nd May 20144:00 pmRNSResult of AGM
22nd May 20147:00 amRNSAGM Statement
19th May 20147:00 amRNSInterim Management Statement
13th May 20144:40 pmRNSSecond Price Monitoring Extn
13th May 20144:35 pmRNSPrice Monitoring Extension
13th May 20147:00 amRNSDirector/PDMR Shareholding
12th May 20147:00 amRNSDirector/PDMR Shareholding
12th May 20147:00 amRNSDirector/PDMR Shareholding
9th May 20147:00 amRNSSale of Aminex USA Inc.
29th Apr 20146:27 pmRNSReplacement: Holding(s) in Company
29th Apr 20145:00 pmRNSNotice of AGM
23rd Apr 20147:00 amRNSFINAL RESULTS AND ANNUAL REPORT
7th Apr 20147:00 amRNSTanzania Exploration Appointment
28th Mar 20144:07 pmRNSFurther re Directorate Changes
27th Mar 20145:36 pmRNSNotice of AGM
27th Mar 20143:32 pmRNSHolding(s) in Company
19th Mar 20144:57 pmRNSFurther Re Directorate Changes
14th Mar 20147:00 amRNSDirectorate Changes
4th Mar 20145:40 pmRNSTotal Voting Rights
4th Mar 20145:38 pmRNSDirector/PDMR Shareholding
3rd Mar 201411:42 amRNSMain Securities Market Notice - Replacement
3rd Mar 201411:39 amRNSMain Securities Market Notice - Replacement
28th Feb 20148:00 amRNSMain Securities Market Notice
27th Feb 20143:51 pmRNSBrochure of Particulars
25th Feb 20147:00 amRNSMain Securities Market Notice
24th Feb 20144:09 pmRNSBrochure of Particulars
24th Feb 20144:05 pmRNSResult of EGM
24th Feb 20147:01 amRNSEGM Presentation
24th Feb 20147:00 amRNSResult of Open Offer
3rd Feb 20147:00 amRNSFORMAL ADDENDUM TO RUVUMA PSA
30th Jan 20145:49 pmRNSIssue of Prospectus and Circular
30th Jan 20144:40 pmRNSSecond Price Monitoring Extn
30th Jan 20144:35 pmRNSPrice Monitoring Extension
30th Jan 20148:13 amRNSPlacing and Open Offer Update
30th Jan 20147:00 amRNSPlacing and Open Offer
9th Jan 20147:01 amRNSDirectorate Change
9th Jan 20147:00 amRNSOperational Update
9th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20137:00 amRNSKiliwani North Update
30th Oct 20137:00 amRNSExtension of Canyon Oil & Gas Agreement Deadline
14th Oct 20137:00 amRNSCompletion of South Weslaco Disposal
17th Sep 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20137:01 amRNSHalf Yearly Report
29th Aug 20137:00 amRNSSenior Appointments & Corporate Acquisition
28th Aug 20137:00 amRNSSouth Weslaco Gas Unit Sale
20th Aug 20134:35 pmRNSPrice Monitoring Extension
19th Aug 20137:00 amRNSTanzania Update
8th Jul 20137:00 amRNSNtorya Appraisal Licence Awarded

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.